This study evaluated individual differences in levels of C-reactive protein (CRP) measured in saliva, crosssectionally and prospectively, in relation to systemic inflammation and risk for cardiovascular disease (CVD). Plasma and saliva samples, later assayed for CRP, were collected multiple times from an ethnically diverse group of women seeking help from domestic violence crisis shelters-agencies (N = 107; mean age at study start = 34 years). Plasma and saliva CRP levels were moderately associated cross-sectionally and across two years. There were indications that saliva CRP levels were, on average, higher in the morning than evening. Higher levels of saliva and plasma CRP were associated with a higher body mass index, but did not differ between women who did and did not smoke. Salivary CRP reliably discriminated between high and low levels of plasma CRP, using a clinically relevant cutoff point of 3 mg/L, recommended by the American Heart Association. Results build upon an emerging literature suggesting that under specific conditions levels of CRP in saliva may reflect low-grade inflammation and have the potential to serve as a screen for CVD risk status.
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Childhood maltreatment and intimate partner violence (IPV) are associated with persistent activation of inflammatory processes (e.g., Danese et al., 2007; Fernandez-Botran et al., 2011) . Studies indeed suggest that inflammation is a key mechanism through which harsh life events affect the development of physical health problems (Danese et al., 2007; Felitti et al., 1998) . Circulating levels of C-reactive protein (CRP) have been employed clinically as an indicator of general inflammation and as a marker of cardiovascular disease risk status (CVD; Pearson et al., 2003) . A handful of studies focused on the assessment of CRP in saliva, and the findings raise the intriguing possibility that saliva may afford a minimally invasive alternative to blood sampling for monitoring CRP (e.g., Quellet-Morin et al., 2011) . Several significant gaps in knowledge remain, and in this study we attempt to fill that gap by exploring the correlates and concomitants of salivary CRP in a high-risk sample of women exposed to IPV. Recent technical advances have made the assessment of a wide range of analytes in saliva possible, creating new opportunities to study how biological and social processes interact and influence health outcomes and human behavior. Compared to other biospecimens such as urine or blood, the assessment of biomarkers in saliva has several advantages (Granger et al., 2007, in press; Pfaffe et al., 2011) : collecting oral fluids does not require skilled professionals and special laboratory equipment, it is generally stress-and pain-free and therefore less burdensome for participants/patients, and it allows for self-and home-based collection. Several immune markers can be detected and reliably assessed in oral fluids, including secretory immunoglobulin A (SIgA), cytokines (e.g., IL-6, IL-8, IL-1b, TNF-a), and acute phase proteins such as CRP (Granger et al., in press; Pfaffe et al., 2011) .
The degree to which levels of immune and inflammatory markers in oral fluids represent systemic immune activity is a key issue. Levels of many immune-related analytes are different in oral fluids than in serum/plasma, and serum-saliva correlations for cytokines and other surrogate markers of inflammation are typically modest (Granger et al., 2006) . The assumption is that the immune system is highly compartmentalized and that local-mucosal secretory and 
